Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia

Neoplasma

Volumn 51, Issue 1, 2004, Pages 56-58

  Dedic K ^a   Zak P ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

2 CdA; 2 chlorodeoxyadenosine; Bone marrow fibrosis; Complete remission; Hairy cell leukemia

Indexed keywords

CLADRIBINE; PENTOSTATIN; RETICULIN;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; HUMAN TISSUE; MALE; MYELOFIBROSIS; PROTEIN LOCALIZATION; REMISSION;

EID: 1342280623     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. BAUERMEISTER DE. Quantification of bone marrow reticulin - a normal range. Am J Clin Pathol 1971; 56: 24-31.
2. BOURONCLE BA, WISEMAN BK, DOAN CA. Leukemic reticuloendotheliosis. Blood 1958; 13: 609-629.
3. BURTHEM J, CAWLEY JC. The bone marrow fibrosis of hairy-cell leukemia is caused by the synthesis and assembly of a fibronectin matrix by the hairy cells. Blood 1994; 83: 497-504.
4. HARMAN DJ. Field worker's forum. Biopsies in leprosy. Lepr Rev 1975; 46: 125-134.
5. PIRO LD, CARRERA CJ, CARSON DA, BEUTLER E. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990; 322: 1117-1121.
6. ROBAK T. Cladribine in the treatment of chronic lymphocytic leukemia. Leuk Lymphoma 2001; 40: 551-564.
7. TEFFERI A, SILVERSTEIN MN, LI CY. 2-Chlorodeoxyadenosine treatment after splenectomy in patients who have myelofibrosis with myeloid metaplasia. Br J Haematol 1997; 99: 352-357.